A Systematic Prediction of Multiple Drug-Target Interactions from Chemical, Genomic, and Pharmacological Data
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
In silico prediction of drug-target interactions from heterogeneous biological data can advance our system-level search for drug molecules and therapeutic targets, which efforts have not yet reached full fruition. In this work, we report a systematic approach that efficiently integrates the chemical, genomic, and pharmacological information for drug targeting and discovery on a large scale, based on two powerful methods of Random Forest (RF) and Support Vector Machine (SVM). The performance of the derived models was evaluated and verified with internally five-fold cross-validation and four external independent validations. The optimal models show impressive performance of prediction for drug-target interactions, with a concordance of 82.83%, a sensitivity of 81.33%, and a specificity of 93.62%, respectively. The consistence of the performances of the RF and SVM models demonstrates the reliability and robustness of the obtained models. In addition, the validated models were employed to systematically predict known/unknown drugs and targets involving the enzymes, ion channels, GPCRs, and nuclear receptors, which can be further mapped to functional ontologies such as target-disease associations and target-target interaction networks. This approach is expected to help fill the existing gap between chemical genomics and network pharmacology and thus accelerate the drug discovery processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
The Nature of Statistical Learning Theory
Vapnik, V. N. (1995) · doi:10.1007/978-1-4757-2440-0 · Cited by 39,138
Wold, S., Esbensen, K., & Geladi, P. (1987) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/0169-7439(87)80084-9 · Cited by 11,606
The Nature of Statistical Learning Theory
Vapnik, V. N. (2000) · Springer eBooks · doi:10.1007/978-1-4757-3264-1 · Cited by 10,696
Lethality and centrality in protein networks
Jeong, H., Mason, S. P., Barabási, A.-L., & Oltvai, Z. N. (2001) · Nature · doi:10.1038/35075138 · Cited by 5,287
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935 · cited 1×
“And Resveratrol has the potential of creating anti-inflammatory and anticancer effects [47,48].”
BackgroundRandom Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling
Svetnik, V., Liaw, A., Tong, C., Culberson, J. C., Sheridan, R. P., & Feuston, B. P. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci034160g · Cited by 3,573
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566 · cited 1×
“For instance, in 2006 only 22 new molecular entities were approved by the Food and Drug Administration (FDA) despite the astronomical research and development expenditures as high as up to $93 billion USD [1].”
BackgroundHow many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505 · cited 4×
“Interestingly, it is found that MDMA binds to the A-1A adrenergic receptor (ADRA1A, binding score = 0.764) and A-2A adrenergic receptor (ADRA2A, binding score = 0.802), which are the targets of 4- methoxyamphetamine (DB01472) [22], a compound structurally similar to MDMA (Figure 9).”
BackgroundMethodInfluential(1998) · Cited by 2,679
Cited by
TCMSP: a database of systems pharmacology for drug discovery from herbal medicines
Ru, J., Li, P., Wang, J., Zhou, W., Li, B., Huang, C., Li, P., Guo, Z., Tao, W., Yang, Y., et al. (2014) · Journal of Cheminformatics · doi:10.1186/1758-2946-6-13 · Cited by 5,038
Self-citationArtificial intelligence in drug discovery and development
Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.010 · Cited by 1,695
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine
Liu, Z., Guo, F., Wang, Y., Li, C., Zhang, X., Li, H., Diao, L., Gu, J., Wang, W., Li, D., et al. (2016) · Scientific Reports · doi:10.1038/srep21146 · Cited by 821
Self-citationDrug–target interaction prediction: databases, web servers and computational models
Chen, X., Yan, C. C., Zhang, X., Zhang, X., Dai, F., Yin, J., & Zhang, Y. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbv066 · Cited by 658
Tao, W., Xu, X., Wang, X., Li, B., Wang, Y., Li, Y., & Yang, L. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.09.051 · Cited by 634
Self-citationToward more realistic drug-target interaction predictions
Pahikkala, T., Airola, A., Pietila, S., Shakyawar, S., Szwajda, A., Tang, J., & Aittokallio, T. (2015) · Briefings in Bioinformatics · doi:10.1093/bib/bbu010 · Cited by 559
Karimi, M., Wu, D., Wang, Z., & Shen, Y. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz111 · Cited by 536
Yao, Z.-J., Dong, J., Che, Y.-J., Zhu, M.-F., Wen, M., Wang, N.-N., Wang, S., Lu, A.-P., & Cao, D.-S. (2016) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-016-9915-2 · Cited by 514
propy: a tool to generate various modes of Chou’s PseAAC
Cao, D.-S., Xu, Q.-S., & Liang, Y.-Z. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt072 · Cited by 476
Machine learning approaches and databases for prediction of drug–target interaction: a survey paper
Bagherian, M., Sabeti, E., Wang, K., Sartor, M. A., Nikolovska-Coleska, Z., & Najarian, K. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbz157 · Cited by 429
Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development
Sarkar, C., Das, B., Rawat, V. S., Wahlang, J. B., Nongpiur, A., Tiewsoh, I., Lyngdoh, N. M., Das, D., Bidarolli, M., & Sony, H. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032026 · Cited by 347
“Moreover, such approaches were adept at presaging drug–target interactions which may be further widened to capture target–disease as well as target–target interactions, hence hastening the drug discovery mechanism [56].”
Liu, H., Wang, J., Zhou, W., Wang, Y., & Yang, L. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.02.004 · Cited by 326
Self-citationEzzat, A., Wu, M., Li, X.-L., & Kwoh, C.-K. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bby002 · Cited by 314
Self-citationThe significance of artificial intelligence in drug delivery system design
Hassanzadeh, P., Atyabi, F., & Dinarvand, R. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.05.001 · Cited by 305
Machine Learning for Drug-Target Interaction Prediction
Chen, R., Liu, X., Jin, S., Lin, J., & Liu, J. (2018) · Molecules · doi:10.3390/molecules23092208 · Cited by 292
Du, P., Gu, S., & Jiao, Y. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15033495 · Cited by 282
Ye, Q., Hsieh, C.-Y., Yang, Z., Kang, Y., Chen, J., Cao, D., He, S., & Hou, T. (2021) · Nature Communications · doi:10.1038/s41467-021-27137-3 · Cited by 261
Zhang, W., Huai, Y., Miao, Z., Qian, A., & Wang, Y. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00743 · Cited by 242
Self-citationNetwork-Based Methods for Prediction of Drug-Target Interactions
Wu, Z., Li, W., Liu, G., & Tang, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01134 · Cited by 237
“, active and inactive DTIs validated by experiments) (Cheng et al., 2012c; Yu et al., 2012; Ding et al., 2014; Chen et al., 2016).”
BackgroundInfluentialShi, H., Liu, S., Chen, J., Li, X., Ma, Q., & Yu, B. (2019) · Genomics · doi:10.1016/j.ygeno.2018.12.007 · Cited by 227
“Machine learning algorithms commonly used in prediction drug-target interactions, such as support vector machine [28,29], K-nearest neighbor [30] and random forest [31], etc.”
MethodSelf-citationThafar, M. A., Olayan, R. S., Ashoor, H., Albaradei, S., Bajic, V. B., Gao, X., Gojobori, T., & Essack, M. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00447-2 · Cited by 143
“Nonetheless, ensemble learning techniques such as RF and Adaboost have proven efficacy when dealing with DTI prediction problems [8, 21, 34, 94, 95].”
MethodHe, S., Leanse, L. G., & Feng, Y. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113922 · Cited by 141
ICAN: Interpretable cross-attention network for identifying drug and target protein interactions
(2022) · doi:10.1371/journal.pone.0276609 · Cited by 19
Yang, L., & Pan, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153800 · Cited by 12
“In order to probe the binding of their targets, SysDT methods were applied [12].”
Method
Metadata
- Authors
- Yu, H., Chen, J., Xu, X., Li, Y., Zhao, H., Fang, Y., Li, X., Zhou, W., Wang, W., & Wang, Y.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-05-30
- Volume
- 7
- Issue
- 5
- Pages
- e37608
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2044002635
- Cited by
- 423
- References
- 66
- FWCI
- 22.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.